Results 161 to 170 of about 17,658 (183)

Geographic Access Disparities of Clinical Trials in Neovascular Age-Related Macular Degeneration in the United States

American Journal of Ophthalmology, 2021
John W Hinkle, Samir Patel, Charlotte Shields   +2 more
exaly  

Neovascular age-related macular degeneration

2010
David E Lederer, Scott W Cousins, Karl G Csaky   +2 more
openaire   +2 more sources

LRG1 Expression Is Elevated in the Eyes of Patients with Neovascular Age-Related Macular Degeneration

International Journal of Molecular Sciences, 2021
Tommaso Bacci, Gian Marco Tôsi, Stefano Lazzi   +2 more
exaly  

Archway Randomized Phase 3 Trial of the Port Delivery System with Ranibizumab for Neovascular Age-Related Macular Degeneration

Ophthalmology, 2022
Shienal Patel, Daniel Miller, Shrirang Ranade   +2 more
exaly  

Current and Novel Therapeutic Approaches for Treatment of Neovascular Age-Related Macular Degeneration

Biomolecules, 2022
Ahmed Sallam, Zain Chauhan
exaly  

Experimental Models in Neovascular Age Related Macular Degeneration

International Journal of Molecular Sciences, 2020
Gilles Pages, Maeva Dufies
exaly  

Neovascular Age-Related Macular Degeneration

2006
ADAM H. ROGERS, ANDRE WITKIN
openaire   +1 more source

Neovascular Age-Related Macular Degeneration and the Risk of Stroke

Stroke, 2010
Henry Lin, Chao-Chien Hu, Jau–Der Ho   +2 more
exaly  

<p>Brolucizumab: evidence to date in the treatment of neovascular age-related macular degeneration</p>

Clinical Ophthalmology, 2019
K Bailey Freund, Nicolas A Yannuzzi
exaly  

Incidence of Macular Atrophy after Untreated Neovascular Age-Related Macular Degeneration

Ophthalmology, 2020
John Campbell, Tiarnán Keenan, Elvira Agron   +2 more
exaly